| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8235196 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 7 Pages |
Abstract
Preoperative chemoradiation with cetuximab-CapIri-RT has manageable toxicity, with diarrhea being the most commonly observed adverse event. Nevertheless, the efficacy of this regimen with a pCR rate of only 8% was significantly lower than that observed in a previous Phase I trial.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Karoline M.D., Anne M.D., Sabine M.D., Manuel M.D., Peter M.D., Philipp M.D., Philipp M.D., Christoph M.D., Dietmar M.D., Georg M.D., Andreas M.D., Stefan M.D., Frank M.D., Frederik M.D., Ralf-Dieter M.D.,